Showing results (41-50 of 242) with videos related to
Sort By:
Pageof 25
Oncogene|January 23, 1997
A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancerV G Brunton, B W Ozanne, C Paraskeva, et al.Current Biology : CB|December 1, 2001
Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activityP Timpson, G E Jones, M C Frame, et al.International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Interaction of nitroimidazole sensitizers with drug metabolizing enzymes--spectral and kinetic studiesF Y Lee, P WorkmanInternational Journal of Cancer|January 2, 1994
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activityJ A Plumb, P WorkmanInternational Journal of Radiation Oncology, Biology, Physics|August 1, 1984
Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069P Workman, M I WaltonInternational Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: structure-activity relationshipsP Workman, P R TwentymanBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1978
Drug latentiation in cancer chemotherapyP Workman, J A DoubleBiochemical Pharmacology|October 1, 1982
Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazolesP Workman, R A WhiteCancer Chemotherapy and Pharmacology|January 1, 1988
When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?L S Freedman, P WorkmanThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in miceM I Walton, P WorkmanPageof 25